TL
Thomas Lenz
Senior Associate at Cipio Partners
Munich, Bavaria
Overview
Thomas Lenz is currently an Investor at Cipio in Munich, Bavaria, specializing in investing in various sectors including Medical Devices, BioTech, and Health IT at different stages such as Series B, Series A, and Seed. With a background in strategy and valuation, he has held roles at notable companies like KPMG and Medtronic, showcasing a strong foundation in financial analysis and strategic decision-making.
Work Experience
Senior Associate
2024 - Current
Growth equity venture capital fund investing in European technology companies Investment team
Associate
2022 - 2024
Board Observer
2024
Board Member
2023
Board Observer
2022 - 2022
Board Observer
2021 - 2022
Investment Manager
2021 - 2022
Venture Capital fund investing in local technology startups (B2B software, deep tech, health tech) Early stage investment team
Assistant Manager | Strategy Group
2020 - 2021
Strategy consulting arm of KPMG, part of Deal Advisory Germany
Senior Associate | Strategy Group
2019 - 2020
Associate | Strategy Group
2018 - 2019
Assistant Manager | Deal Advisory, Valuation (Rotation)
2020 - 2021
Master Thesis Student
2018 - 2018
M&A of Medtronic and Covidien: Post merger integration analysis and creation of a success measurement model
Student Associate | Strategy, Pricing
2017 - 2018
Largest global medical technology company
Medtronic is a healthcare technology company that designs and develops AI-based products and solutions for the medical industry.
Raised $9,105,978,217.00 from NHS England.
Co-Founder
2015 - 2016
Co-founded a company providing smartphone courses for seniors